ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
UK parliamentary enquiry threatens to disclose details of Vertex, NHS negotiations over Orkambi
November 12, 2018The UK House of Commons' Health and Social Care Committee on Friday said that it requested documents from Vertex Pharmaceuticals, NHS England and the -
Ministers write letter to Vertex over Orkambi debate
July 16, 2018Ministers from the Department of Health have written a letter asking that Vertex bring negotiations with NHS England over access to cystic fibrosis drug Orkambi “to an urgent resolution”. -
Vertex’ CF therapy Orkambi cleared for younger patients
January 11, 2018European regulators have expanded the scope of Vertex’ Orkambi to include children with cystic fibrosis aged six through 11 who have two copies of the F508del mutation. -
Vertex Receives CHMP Positive Opinion for ORKAMBI for Children with Cystic Fibrosis
November 13, 2017Positive CHMP opinions are recommendations for approval to the European Commission, which has the authority to approve medicines for the European Union.
Pharma Sources Insight January 2025
